Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2015, Article ID 730285, 6 pages
http://dx.doi.org/10.1155/2015/730285
Research Article

Prevalence of Hyposalivation in Patients with Systemic Lupus Erythematosus in a Brazilian Subpopulation

1Department of Oral Pathology, University of Cuiabá, Avenida Manoel José de Arruda 3.100 Jardim Europa, 78065-900 Cuiabá, MT, Brazil
2Department of Pathology, Federal Fluminense University, Rua Marquês do Paraná 303, No. 4 Andar do Prédio Principal, Sala 1, 24.033-900 Niterói, RJ, Brazil
3Department of Pediatrics, School of Medicine, Federal University of Mato Grosso, Avenida Fernando Corrêa da Costa 2367, Boa Esperança, 78060-900 Cuiabá, MT, Brazil
4Department of Statistics, Institute of Exact Sciences, Federal University of Mato Grosso, Avenida Fernando Corrêa da Costa 2367, Boa Esperança, 78060-900 Cuiabá, MT, Brazil
5School of Dentistry, University of Cuiabá, Brazil Avenida Manoel José de Arruda 3.100, Jardim Europa, 78065-900 Cuiabá, MT, Brazil
6Department of Rheumatology, University of Cuiabá, Avenida Manoel José de Arruda 3.100, Jardim Europa, 78065-900 Cuiabá, MT, Brazil
7Faculty of Dentistry, University of Cuiabá, Avenida Manoel José de Arruda 3.100, Jardim Europa, 78065-900 Cuiabá, MT, Brazil

Received 30 September 2014; Accepted 16 December 2014

Academic Editor: Lisa Rider

Copyright © 2015 Cristhiane Almeida Leite et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S.-L. Yu, W.-P. Kuan, C.-K. Wong, E. K. Li, and L.-S. Tam, “Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus,” Clinical and Developmental Immunology, vol. 2012, Article ID 715190, 14 pages, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. E. Aberer, “Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus,” Lupus, vol. 19, no. 9, pp. 1118–1124, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. A. K. Nakashima, A. P. Galhardo, J. F. M. da Silva et al., “Incidência e aspectos clínico-laboratoriais do lúpus eritematoso sistêmico em cidade do sul do Brasil,” Revista Brasileira de Reumatologia, vol. 51, no. 3, pp. 235–239, 2011. View at Publisher · View at Google Scholar
  5. R. Jonsson, G. Heyden, N. G. Westberg, and G. Nyberg, “Oral mucosal lesions in systemic lupus erythematosus,” Journal of Rheumatology, vol. 11, no. 1, pp. 38–42, 1984. View at Google Scholar · View at Scopus
  6. S. M. Burge, P. A. Frith, R. P. Juniper, and F. Wojnarowska, “Mucosal involvement in systemic and chronic cutaneous lupus erythematosus,” British Journal of Dermatology, vol. 121, no. 6, pp. 727–741, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Alarcón-Segovia, G. Ibánez, F. Velazquez-Forero, J. Hernandez-Ortiz, and Y. Gonzalez-Jimenez, “Sjogren’s syndrome in systemic lupus erythematosus: clinical and subclinical manifestations,” Annals of Internal Medicine, vol. 81, pp. 577–583, 1974. View at Google Scholar
  8. M. T. Brennan, M. A. Valerin, J. J. Napeñas, and P. B. Lockhart, “Oral manifestations of patients with lupus erythematosus,” Dental Clinics of North America, vol. 49, no. 1, pp. 127–141, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. N. L. Rhodus and D. K. Johnson, “The prevalence of oral manifestations of systemic lupus erythematosus,” Quintessence International, vol. 21, no. 6, pp. 461–465, 1990. View at Google Scholar · View at Scopus
  10. J. López-Labady, M. Villarroel-Dorrego, N. González, R. Pérez, and M. M. de Henning, “Oral manifestations of systemic and cutaneous lupus erythematosus in a Venezuelan population,” Journal of Oral Pathology & Medicine, vol. 36, no. 9, pp. 524–527, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. B. Albilia, D. K. Lam, C. M. L. Clokie, and G. K. B. Sándor, “Systemic lupus erythematosus: a review for dentists,” Journal of the Canadian Dental Association, vol. 73, no. 9, pp. 823–828, 2007. View at Google Scholar · View at Scopus
  12. S. V. Lourenço, F. R. G. de Carvalho, P. Boggio et al., “Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate,” Journal of Cutaneous Pathology, vol. 34, no. 7, pp. 558–564, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. N. Ángel, N. Echeverry, P. Restrepo, L. González, L. Rodríguez, and G. Vásquez, “Manifestaciones bucales en pacientes con lupus eritematoso sistémico: oral manifestations in patients with Systemic Lupus Erythematosus,” Revista Colombiana de Reumatología, vol. 17, no. 1, pp. 13–21, 2010. View at Publisher · View at Google Scholar
  14. M. F. Orellana, M. O. Lagravère, D. G. J. Boychuk, P. W. Major, and C. Flores-Mir, “Prevalence of xerostomia in population-based samples: a systematic review,” Journal of Public Health Dentistry, vol. 66, no. 2, pp. 152–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ben-Aryeh, N. Gordon, R. Szargel, E. Toubi, and D. Laufer, “Whole saliva in systemic lupus erythematosus patients,” Oral Surgery Oral Medicine and Oral Pathology, vol. 75, no. 6, pp. 696–699, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Fernandes, M. M. S. Nico, V. Aoki et al., “Xerostomia in Sjögren's syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations,” Journal of Cutaneous Pathology, vol. 37, no. 4, pp. 432–438, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. Jonsson, D. Bratthall, and G. Nyberg, “Histologic and sialochemical findings indicating sicca syndrome in patients with systemic lupus erythematosus,” Oral Surgery Oral Medicine and Oral Pathology, vol. 54, no. 6, pp. 635–639, 1982. View at Publisher · View at Google Scholar · View at Scopus
  18. I. von Bültzingslöwen, T. P. Sollecito, P. C. Fox et al., “Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 103, supplement, pp. S57.e1–S57.e15, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. P. Güneri, E. Alpöz, J. B. Epstein, H. Çankaya, and M. Ates, “In vitro antimicrobial effects of commercially available mouth-wetting agents,” Special Care in Dentistry, vol. 31, no. 4, pp. 123–128, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. D. P. Falcão, L. M. H. da Mota, A. L. Pires, and A. C. B. Bezerra, “Sialometry: aspects of clinical interest,” Revista Brasileira de Reumatologia, vol. 53, no. 6, pp. 525–531, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. E. Maeshima, K. Furukawa, S. Maeshima, H. Koshiba, and W. Sakamoto, “Hyposalivation in autoimmune diseases,” Rheumatology International, vol. 33, no. 12, pp. 3079–3082, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. E. A. F. De Araújo Navas, E. I. Sato, D. F. A. Pereira et al., “Oral microbial colonization in patients with systemic lupus erythematous: correlation with treatment and disease activity,” Lupus, vol. 21, no. 9, pp. 969–977, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. E. Spolarich, “Risk management strategies for reducing oral adverse drug events,” Journal of Evidence-Based Dental Practice, vol. 14, supplement, pp. 87.e1–94.e1, 2014. View at Publisher · View at Google Scholar · View at PubMed
  24. J. Kałuzny, M. Wierzbicka, H. Nogala, P. Milecki, and T. Kopeć, “Radiotherapy induced xerostomia: mechanisms, diagnostics, prevention and treatment—evidence based up to 2013,” Otolaryngologia Polska, vol. 68, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. R. Martinez, Treatment of Salivary Gland Disorders: Alternative Approaches, 2013, http://www.nidcr.nih.gov/oralhealth/Topics/Saliva/AlternativeApproaches.htm.
  26. E. A. Field, L. P. Longman, R. Bucknall, S. B. Kaye, S. M. Higham, and W. M. Edgar, “The establishment of a xerostomia clinic: a prospective study,” British Journal of Oral and Maxillofacial Surgery, vol. 35, no. 2, pp. 96–103, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. T. O. Närhi, J. H. Meurman, and A. Ainamo, “Xerostomia and hyposalivation: causes, consequences and treatment in the elderly,” Drugs and Aging, vol. 15, no. 2, pp. 103–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. I.-M. Gilboe, T. K. Kvien, T. Uhlig, and G. Husby, “Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables,” Annals of the Rheumatic Diseases, vol. 60, no. 12, pp. 1103–1109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Hochberg, “Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Bombardier, D. D. Gladman, M. B. Urowitz et al., “Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE,” Arthritis and Rheumatism, vol. 35, no. 6, pp. 630–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Petri, M. Genovese, E. Engle, and M. Hochberg, “Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study,” Arthritis & Rheumatism, vol. 34, no. 8, pp. 937–944, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Navazesh and S. K. Kumar, “Measuring salivary flow: challenges and opportunities,” Journal of the American Dental Association, vol. 139, no. 2, pp. 35S–40S, 2008. View at Publisher · View at Google Scholar
  33. C. Dawes, “Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man,” Journal of Dental Research, vol. 66, pp. 648–653, 1987. View at Google Scholar · View at Scopus
  34. D. M. Grennan, M. Ferguson, J. Williamson, M. Mavrikakis, W. C. Dick, and W. W. Buchanan, “Sjogren's syndrome in Systemic Lupus Erythematosus. Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with systemic lupus erythematosus,” New Zealand Medical Journal, vol. 86, no. 598, pp. 374–376, 1977. View at Google Scholar · View at Scopus
  35. A. P. Andonopoulos, F. N. Skopouli, G. S. Dimou, A. A. Drosos, and H. M. Moutsopoulos, “Sjögren’s syndrome in systemic lupus erythematosus,” Journal of Rheumatology, vol. 17, no. 2, pp. 201–204, 1990. View at Google Scholar · View at Scopus
  36. J. L. Jensen, H. O. Bergem, I.-M. Gilboe, G. Husby, and T. Axéll, “Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus,” Journal of Oral Pathology & Medicine, vol. 28, no. 7, pp. 317–322, 1999. View at Google Scholar · View at Scopus
  37. L. M. Streebny and A. Valdini, “Xerostomia. Part I: relationship to other oral symptoms and salivary gland hypofunction,” Oral Surgery Oral Medicine and Oral Pathology, vol. 66, no. 4, pp. 451–458, 1988. View at Publisher · View at Google Scholar · View at Scopus
  38. C.-K. Yeh, D. A. Johnson, and M. W. J. Dodds, “Impact of aging on human salivary gland function: a community-based study,” Aging Clinical and Experimental Research, vol. 10, no. 5, pp. 421–428, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Flink, M. Bergdahl, Å. Tegelberg, A. Rosenblad, and F. Lagerlöf, “Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults,” Community Dentistry and Oral Epidemiology, vol. 36, no. 6, pp. 523–531, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. F. Cassolato and R. S. Turnbull, “Xerostomia: clinical aspects and treatment,” Gerodontology, vol. 20, no. 2, pp. 64–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Vitali, H. M. Moutsopoulos, and S. Bombardieri, “The European Community Study Group on diagnostic criteria for Sjögren’s syndrome. Sensiti vity and specificity of tests for ocular and oral involvement in Sjögren’s syndrome,” Annals of the Rheumatic Diseases, vol. 53, no. 10, pp. 637–647, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. R. S. Percival, S. J. Challacombe, and P. D. Marsh, “Flow rates of resting whole and stimulated parotid saliva in relation to age and gender.,” Journal of Dental Research, vol. 73, no. 8, pp. 1416–1420, 1994. View at Google Scholar · View at Scopus
  43. A. Gupta, J. B. Epstein, and H. Sroussi, “Hyposalivation in elderly patients,” Journal of the Canadian Dental Association, vol. 72, no. 9, pp. 841–846, 2006. View at Google Scholar · View at Scopus